Literature DB >> 6897037

Vitamin D stimulates prolactin synthesis by GH4C1 cells incubated in chemically defined medium.

J D Wark, A H Tashjian.   

Abstract

GH4C1 cells were evaluated as a model system for the investigation of the cellular and molecular mode of action of vitamin D. When cells were incubated in hormone-free, chemically defined medium, the metabolite 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) potently stimulated PRL synthesis (ED50 = 2 x 10(-10) M) with minimal effects on GH synthesis. The stimulation of PRL synthesis was vitamin D metabolite specific. The effect of 1,25-(OH)2D3 was dependent on the addition of extracellular calcium in the concentration range up to 0.1 mM. These results indicate the potential usefulness of this experimental system for the study of vitamin D action.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897037     DOI: 10.1210/endo-111-5-1755

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Glucocorticoids antagonize induction of prolactin-gene expression by calcitriol in rat pituitary tumour cells.

Authors:  J D Wark; V Gurtler
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

2.  TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults.

Authors:  I Barchetta; M G Baroni; F Leonetti; M De Bernardinis; L Bertoccini; M Fontana; E Mazzei; A Fraioli; M G Cavallo
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

3.  Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.

Authors:  K Törnquist; L Forss; C Lamberg-Allardt
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

4.  Steroid inhibition of calcitriol-induced prolactin production in GH4C1 cells. Specificity and sensitivity.

Authors:  J D Wark; V Gurtler
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion.

Authors:  M C d'Emden; J D Wark
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

Review 6.  Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

Authors:  S Christakos; M Raval-Pandya; R P Wernyj; W Yang
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

7.  Modulation by 1,25-dihydroxycholecalciferol of the acute change in cytosolic free calcium induced by thyrotropin-releasing hormone in GH4C1 pituitary cells.

Authors:  J C Chisholm; S Kim; A H Tashjian
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

8.  Vitamin D sites of action in the pituitary studied by combined autoradiography-immunohistochemistry.

Authors:  W E Stumpf; M Sar; L P O'Brien
Journal:  Histochemistry       Date:  1987

Review 9.  Hormonal regulation of cytosolic free calcium and its functional consequences: the GH-cell model.

Authors:  A H Tashjian
Journal:  Environ Health Perspect       Date:  1990-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.